Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Equity Ratio (2016 - 2025)

Vanda Pharmaceuticals' Equity Ratio history spans 16 years, with the latest figure at 0.67 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 18.46% to 0.67 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.67, a 18.46% decrease, with the full-year FY2025 number at 0.67, down 18.46% from a year prior.
  • Equity Ratio hit 0.67 in Q4 2025 for Vanda Pharmaceuticals, down from 0.78 in the prior quarter.
  • Over the last five years, Equity Ratio for VNDA hit a ceiling of 0.86 in Q1 2021 and a floor of 0.67 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.82 across 5 years, with a median of 0.83 in 2024.
  • Biggest five-year swings in Equity Ratio: grew 2.07% in 2023 and later dropped 18.46% in 2025.
  • Tracing VNDA's Equity Ratio over 5 years: stood at 0.85 in 2021, then dropped by 2.25% to 0.83 in 2022, then grew by 1.1% to 0.84 in 2023, then dropped by 2.34% to 0.82 in 2024, then decreased by 18.46% to 0.67 in 2025.
  • Business Quant data shows Equity Ratio for VNDA at 0.67 in Q4 2025, 0.78 in Q3 2025, and 0.78 in Q2 2025.